Dr. Mhd Hicham Alnachawati, MD, MPH Preventive Medicine - Occupational Medicine Medicare: May Accept Medicare Assignments Practice Location: 2960 Victory Blvd, Staten Island, NY 10314 Phone: 718-370-2014 |
Dr. Marc William Manseau, M.D. Medicare: Medicare Enrolled Practice Location: 777 Seaview Ave Bldg 2nd, Staten Island, NY 10305 Phone: 347-687-4704 |
Dr. George Anastasios Pourakis, MD, MPH Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 215 Drum Rd, D-113, Staten Island, NY 10305 Phone: 718-354-4414 |
News Archive
Nine studies presented at the Experimental Biology 2007 meeting support the growing body of research on the nutritional benefits of egg consumption, including its promotion of weight loss and its role in providing choline, an essential nutrient often lacking in the diet that promotes brain and memory development and function.
The simple pleasure of tasting and savoring food is "an important part of anyone's daily life," says University of Massachusetts Amherst sensory scientist Alissa Nolden.
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5362 (CLO-FAST), a clinical trial studying a three-month clofazimine- and high-dose rifapentine-containing treatment regimen for people with drug-susceptible tuberculosis (TB).
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
› Verified 8 days ago